RELGAABI
NDC 58657-233, Gabapentin, capsule, from Method Pharmaceuticals, LLC.
- Product NDC
- 58657-233
- Status
- Listed
- Labeler
- Method Pharmaceuticals, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204989
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58657-233 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN300 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58657-233-01 | 58657023301 | 100 CAPSULE in 1 BOTTLE, PLASTIC (58657-233-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4cc6615b-5447-9c0e-e063-6394a90a2883NADAC price for package 58657023301
GET /v1/drugs/nadac/58657023301
Use it
Look up 58657-233 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58657-233 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58657-233. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.